Combined Use of Tricyclic Antidepressants and Neuroleptics in the Management of Terminally 111 Children: A Report on Three Cases

6Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Three children with terminal cancer, ages 7, 9, and 14 years, who exhibited severe symptoms of depression and anxiety, were treated with a combination of low dose amitriptyline (1–2 mg/kg/24 hours) and haloperidol (0.05–0.10 mg/kg/24 hours). Anxiety decreased, mood improved, vegetative symptoms were alleviated, and requirements for narcotic analgesia decreased within 1 week of inception of pharmacotherapy. Symptoms reemerged in two patients when the medications were discontinued. Importantly, the psychopharmaco-logic interventions allowed the patients and their families to deal with the dynamic issues involved in chronic illness and death and dying. © 1985, The American Academy of Child Psychiatry. All rights reserved.

Cite

CITATION STYLE

APA

MAISAMI, M., SOHMER, B. H., & COYLE, J. T. (1985). Combined Use of Tricyclic Antidepressants and Neuroleptics in the Management of Terminally 111 Children: A Report on Three Cases. Journal of the American Academy of Child Psychiatry, 24(4), 487–489. https://doi.org/10.1016/S0002-7138(09)60569-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free